Griffin Concierge Medical has been acquired by Revelstoke Capital Partners
Griffin Concierge Medical, a full-service concierge primary care group, has been acquired by Revelstoke Capital Partners, a healthcare-focused private equity firm.
Founded in 2008, Griffin Concierge Medical is a physician-owned, multi-site, membership-based concierge primary and preventive care provider headquarted in Tampa, Florida. The practice offers a full range of personalized services, including preventive screenings, advanced diagnostics, hormone optimization, weight management, nutritional counseling and round-the-clock access to dedicated physicians. Recognized as a leader in the market’s premium segment, Griffin Concierge Medical is well positioned as a scalable platform in consumer healthcare.
Revelstoke Capital Partners is a Denver-based private equity firm with approximately US$5.5 billion of assets under management. Founded in 2013, the firm focuses on building industry-leading companies in healthcare services, healthcare technology and health and wellness.
Oaklins TM Capital in the USA served as the exclusive financial advisor to Griffin Concierge Medical in its sale to Revelstoke Capital Partners.
Dr. Radley Griffin
Founder, Griffin Concierge Medical
Talk to the deal team
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more